Headache & TMJ Center of New Jersey
- Laser Therapy (LLLT)
- Ketamine Therapy
- Migraine Treatment
- TMJ Treatment
New Jersey
Ketamine therapy in New Jersey is not evenly spread across the state, and patients searching for clinics that pair the medication with integrated psychiatric care tend to find the most options in the northern metro area around Hudson County and Newark, with further clusters in Central Jersey near New Brunswick, Morristown, and Princeton. South Jersey has fewer standalone options, and residents there, along with many in the northeast corner of the state, often weigh clinics just across the border in New York City or Philadelphia rather than assuming every service exists within New Jersey's own borders. If you are outside these metro areas, confirm distance and appointment cadence before committing to a course of treatment.
Ketamine is a federally controlled substance, and in New Jersey it is typically administered in a physician's office, a monitored infusion suite, or a psychiatric practice rather than a general wellness setting. Clinics that advertise integrated psychiatric care usually mean a psychiatrist or psychiatric nurse practitioner is involved in evaluation and follow-up alongside whoever administers the medication, which matters most for treatment-resistant depression, since dosing without psychiatric continuity is a different service than dosing with it. New Jersey does not have a separate ketamine-specific licensing track, so scope of practice follows the general rules for physicians, physician assistants, and advanced practice nurses.
You can verify a provider's standing through the New Jersey State Board of Medical Examiners for physicians and physician assistants, and the New Jersey Board of Nursing for nurses and nurse practitioners, both reachable through the state's Division of Consumer Affairs. A clean license record confirms standing, not outcomes. Before booking anywhere in the state, ask who evaluates you, who is physically present during administration, exactly what is being given and where it is sourced from, how risks are disclosed in writing, what happens if the treatment does not help, and for an itemized quote covering evaluation, medication, monitoring, and any psychotherapy.
This listing's order is not for sale. Featured slots are labeled and capped, Verified means the clinic completed credential checks rather than paid for placement, and Regenerated.com is free for patients; inclusion here is not an endorsement. The national ketamine therapy hub covers mechanism and evidence in more depth. For more on how to read this list, see How to read a Regenerated city hub and Featured vs Verified vs organic.
Regulatory context
Ketamine is a DEA Schedule III controlled substance, FDA-approved as a dissociative anesthetic and used off-label for treatment-resistant depression, PTSD, and chronic pain. The FDA approved esketamine (Spravato) in 2019 for treatment-resistant depression under a Risk Evaluation and Mitigation Strategy (REMS) program that requires in-office administration at certified sites. MDMA-assisted therapy remains Schedule I; the FDA issued a Complete Response Letter in August 2024 to Lykos Therapeutics on its MDMA new drug application. Psilocybin is Schedule I and holds FDA Breakthrough Therapy designation through sponsors such as Compass Pathways and Usona, but has not received FDA approval. Oregon Measure 109 (passed 2020, operational 2023) created a state psilocybin service center framework, and Colorado Proposition 122 (2022) authorized regulated healing centers.
New Jersey enforces federal scheduling with modest state-level softening of possession penalties. The New Jersey State Board of Medical Examiners oversees prescriber conduct. DEA enforcement on ketamine clinics focuses on diversion and Ryan Haight Act telehealth rules. NJ PMP requires controlled substance reporting.
Treatment nearby
More in this state
Nationwide
Ketamine Therapy clinics across the US